Form4insider filings, from the source

Insider holders · CIK 0001725160

Zentalis Pharmaceuticals, Inc. · ZNTL

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Susan Berkley Walters10% Owner17,844,973—17,844,973Aug 19, 2026 · 6:11 pm EDTForm 4
William Thurman Walters10% Owner17,844,973—17,844,973Aug 19, 2026 · 6:11 pm EDTForm 4
WALTERS GROUP10% Owner17,844,973—17,844,973Aug 19, 2026 · 6:11 pm EDTForm 4
Scott Dunseth MyersDirector395,895—395,895Jun 18, 2026 · 4:06 pm EDTForm 4
David Michael JohnsonDirector307,521—307,521Jun 18, 2026 · 4:09 pm EDTForm 4
Jan SkvarkaDirector264,254—264,254Jun 18, 2026 · 4:08 pm EDTForm 4
Luke Nathaniel WalkerDirector201,384—201,384Jun 18, 2026 · 4:07 pm EDTForm 4
Enoch KariukiDirector194,465—194,465Jun 18, 2026 · 4:07 pm EDTForm 4

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.